The IMF's Patience with the ECB Wears Thin
The updated World Economic Outlook reveals that the IMF is (rightly) fed up with the ECB’s timid approach to monetary policy. Monetary policy in...
507 Views
Never Trust A Swiss Central Banker
Post SNB surprise announcement yesterday - after leading the market on as recently as a few weeks ago on – the term “Never trust a Swiss central...
517 Views
Samsung Biologics (207940 KS): 1Q25 Operating and Net Profits Doubled; 2025 Guidance Maintained
Samsung Biologics sees 120% operating profit growth in 1Q25, driven by stable plant utilizations and Fx tailwind. The company maintained full-year...
423 Views
Samsung Biologics (207940 KS): Record High Revenue in 2024; Accelerated Growth Expected in 2025
Samsung Biologics exceeded revenue expectations in 2024, driven by Plant 4 ramp-up and milestone payments. With Plant 5 set to increase capacity,...
620 Views
Rubicon Research Pre-IPO - Robust Product Development Pipeline Driving Revenue Growth
Rubicon Research Limited is looking to raise about US$130m in its India IPO. In this note, we talk about the company’s historical performance.
534 Views